Acknowledgement
Supported by : Seoul National University Bundang Hospital
References
- Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One 2015;10:e0126982. https://doi.org/10.1371/journal.pone.0126982
- Madani S, Parikh S, Madani RS, Krasaelap A. Long-term study of children with rome III functional gastrointestinal disorders managed symptomatically in a biopsychosocial model. Gastroenterology Res 2017;10:84-91. https://doi.org/10.14740/gr798w
- Horst S, Shelby G, Anderson J, et al. Predicting persistence of functional abdominal pain from childhood into young adulthood. Clin Gastroenterol Hepatol 2014;12:2026-2032. https://doi.org/10.1016/j.cgh.2014.03.034
- Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology 2016;150:1456-1468, e2. https://doi.org/10.1053/j.gastro.2016.02.015
- Schmulson MJ, Drossman DA. What is new in rome IV. J Neurogastroenterol Motil 2017;23:151-163. https://doi.org/10.5056/jnm16214
- Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol 2011;46:421-431. https://doi.org/10.1007/s00535-011-0379-9
- Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014;63:262-271. https://doi.org/10.1136/gutjnl-2012-303857
- Wauters L, Nightingale S, Talley NJ, Sulaiman B, Walker MM. Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort. Aliment Pharmacol Ther 2017;45:1358-1364. https://doi.org/10.1111/apt.14045
- Schurman JV, Singh M, Singh V, Neilan N, Friesen CA. Symptoms and subtypes in pediatric functional dyspepsia: relation to mucosal inflammation and psychological functioning. J Pediatr Gastroenterol Nutr 2010;51:298-303.
- Lee EH, Yang HR, Lee HS. Analysis of gastric and duodenal eosinophils in children with abdominal pain related functional gastrointestinal disorders according to rome III criteria. J Neurogastroenterol Motil 2016;22:459-469. https://doi.org/10.5056/jnm15174
- Yantiss RK. Eosinophils in the GI tract: how many is too many and what do they mean? Mod Pathol 2015;28(suppl 1):S7-S21. https://doi.org/10.1038/modpathol.2014.132
- DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 2006;9:210-218. https://doi.org/10.2350/11-05-0130.1
- Saad AG. Normal quantity and distribution of mast cells and eosinophils in the pediatric colon. Pediatr Dev Pathol 2011;14:294-300. https://doi.org/10.2350/10-07-0878-OA.1
- Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc 2004;60:505-512. https://doi.org/10.1016/S0016-5107(04)01878-4
- Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012;61:535-542. https://doi.org/10.1136/gutjnl-2011-300486
- Travis SP, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology 2013;145:987-995. https://doi.org/10.1053/j.gastro.2013.07.024
- Travers J, Rothenberg ME. Eosinophils in mucosal immune responses. Mucosal Immunol 2015;8:464-475. https://doi.org/10.1038/mi.2015.2
- Wang X, Li X, Ge W, et al. Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia. Ann Diagn Pathol 2015;19:50-56. https://doi.org/10.1016/j.anndiagpath.2015.02.001
- Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil 2010;16:251-257. https://doi.org/10.5056/jnm.2010.16.3.251
- Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol 2010;7:146-156. https://doi.org/10.1038/nrgastro.2010.5
- Walker MM, Talley NJ, Prabhakar M, et al. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009;29:765-773. https://doi.org/10.1111/j.1365-2036.2009.03937.x
- Piche T, Saint-Paul MC, Dainese R, et al. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome. Gut 2008;57:468-473.
- O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-457. https://doi.org/10.1046/j.1365-2982.2000.00221.x
- Friesen CA, Andre L, Garola R, Hodge C, Roberts C. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr 2002;35:329-333. https://doi.org/10.1097/00005176-200209000-00017
- Friesen CA, Neilan NA, Schurman JV, Taylor DL, Kearns GL, Abdel-Rahman SM. Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics. BMC Gastroenterol 2009;9:32. https://doi.org/10.1186/1471-230X-9-32
- Friesen CA, Lin Z, Singh M, et al. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci 2008;53:2634-2640. https://doi.org/10.1007/s10620-008-0207-0
- Friesen CA, Kearns GL, Andre L, Neustrom M, Roberts CC, Abdel-Rahman SM. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004;38:343-351. https://doi.org/10.1097/00005176-200403000-00021
- Mehta P, Furuta GT. Eosinophils in gastrointestinal disorders: eosinophilic gastrointestinal diseases, celiac disease, inflammatory bowel diseases, and parasitic infections. Immunol Allergy Clin North Am 2015;35:413-437. https://doi.org/10.1016/j.iac.2015.04.003
- Zezos P, Patsiaoura K, Nakos A, et al. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy. Colorectal Dis 2014;16:O420-O430. https://doi.org/10.1111/codi.12725
- Kristjansson G, Venge P, Wanders A, Loof L, Hallgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806-1812. https://doi.org/10.1136/gut.2003.036418
- Woodruff SA, Masterson JC, Fillon S, Robinson ZD, Furuta GT. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J Pediatr Gastroenterol Nutr 2011;52:650-661. https://doi.org/10.1097/MPG.0b013e3182128512
- Katsanos KH, Zinovieva E, Lambri E, Tsianos EV. Eosinophilic-Crohn overlap colitis and review of the literature. J Crohns Colitis 2011;5:256-261. https://doi.org/10.1016/j.crohns.2011.02.009
- Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest 2015;45:1350-1359. https://doi.org/10.1111/eci.12548
- Talley NJ, Walker MM, Holtmann G. Functional dyspepsia. Curr Opin Gastroenterol 2016;32:467-473. https://doi.org/10.1097/MOG.0000000000000306
- Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010;1:97-105. https://doi.org/10.4291/wjgp.v1.i3.97
- Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep 2011;13:323-330. https://doi.org/10.1007/s11894-011-0197-5
- Bashashati M, Moossavi S, Cremon C, et al. Colonic immune cells in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil 2018;30.
- Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut 2016;65:155-168. https://doi.org/10.1136/gutjnl-2015-309151
- Ohman L, Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010;7:163-173. https://doi.org/10.1038/nrgastro.2010.4
- Bass JA, Friesen CA, Deacy AD, et al. Investigation of potential early histologic markers of pediatric inflammatory bowel disease. BMC Gastroenterol 2015;15:129. https://doi.org/10.1186/s12876-015-0359-2
- Pensabene L, Brundler MA, Bank JM, Di Lorenzo C. Evaluation of mucosal eosinophils in the pediatric colon. Dig Dis Sci 2005;50:221-229. https://doi.org/10.1007/s10620-005-1586-0
- Flores C, Francesconi CF, Meurer L. Quantitative assessment of CD30+ lymphocytes and eosinophils for the histopathological differential diagnosis of inflammatory bowel disease. J Crohns Colitis 2015;9:763-768. https://doi.org/10.1093/ecco-jcc/jjv097
- Carvalho AT, Elia CC, de Souza HS, et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J Clin Gastroenterol 2003;36:120-125. https://doi.org/10.1097/00004836-200302000-00006
- Hurrell JM, Genta RM, Melton SD. Histopathologic diagnosis of eosinophilic conditions in the gastrointestinal tract. Adv Anat Pathol 2011;18:335-348. https://doi.org/10.1097/PAP.0b013e318229bfe2
- Chernetsova E, Sullivan K, de Nanassy J, et al. Histologic analysis of eosinophils and mast cells of the gastrointestinal tract in healthy Canadian children. Hum Pathol 2016;54:55-63. https://doi.org/10.1016/j.humpath.2016.03.004